StonvexLoading…
StonvexStonvexStonvexCore line items from AG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.26B | $560.60M | $573.80M | $624.22M |
Operating Income | $397.07M | $-3.75M | $-178.78M | $-39.19M |
Net Income | $210.97M | $-101.89M | $-135.11M | $-114.28M |
EPS (Diluted) | $0.34 | $-0.34 | $-0.48 | $-0.43 |
Total Assets | $4.69B | $1.98B | $1.98B | $2.11B |
Total Liabilities | $1.52B | $628.72M | $618.24M | $698.71M |
Cash & Equivalents | $793.43M | $202.18M | $125.58M | $151.44M |
Free Cash Flow OCF − CapEx | $463.91M | $131.95M | $23.63M | $-40.72M |
Shares Outstanding | Not available | Not available | Not available | Not available |